Home NDC 0008-1030-06 Rapamune
Product NDC 0008-1030
Requested package NDC 0008-1030-06
11-digit product format 000081030
Labeler code 0008
Product ID 0008-1030_88b60b59-91f1-445d-a08f-a0a55c69d2d9
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name SIROLIMUS
Dosage form SOLUTION
Route ORAL
Labeler Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Application NDA021083
Marketing category NDA
Marketing start 1999-09-01
Marketing end 0000-00-00
Substance SIROLIMUS
Active strength 1 mg/mL
Pharmacologic classes Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 6 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021083-001 RAPAMUNE SIROLIMUS 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N021083-001 AA
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N021083-001 RAPAMUNE 1MG/ML SOLUTION / ORAL AA RLD, RS 1999-09-15 f41ea6bd6efb…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 43 observed states.
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded SIROLIMUS ACTIVE INGREDIENT W36ZG6FT64 RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 SIROLIMUS ACTIVE MOIETY W36ZG6FT64 RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 .ALPHA.-TOCOPHEROL ACETATE INACTIVE INGREDIENT 9E8X80D2L0 RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 CALCIUM SULFATE INACTIVE INGREDIENT WAT0DDB505 RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 CARNAUBA WAX INACTIVE INGREDIENT R12CBM0EIZ RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 GLYCERYL OLEATE INACTIVE INGREDIENT 4PC054V79P RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 POLOXAMER 188 INACTIVE INGREDIENT LQA7B6G8JG RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 POLYETHYLENE GLYCOL 8000 INACTIVE INGREDIENT Q662QK8M3B RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 POVIDONE K29/32 INACTIVE INGREDIENT 390RMW2PEQ RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 SUCROSE INACTIVE INGREDIENT C151H8M554 RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 TALC INACTIVE INGREDIENT 7SEV7J4R1U RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] 47
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0008-1030 RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS LLC, A SUBSIDIARY OF PFIZER INC.] 73 Legacy NDC 20250110_3275b824-3f82-4151-2ab2-0036a9ba0acc.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0008-1030-06 00008103006 1 CARTON in 1 KIT (0008-1030-06) > 1 BOTTLE, GLASS in 1 CARTON (0008-1030-04) > 60 mL in 1 BOTTLE, GLASS 1 carton 1999-09-01 0000-00-00 No No Current